Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis

por Negida, Ahmed, Ghaith, Hazem S., Fala, Salma Yousry, Ahmed, Hussien, Bahbah, Eshak I, Ebada, Mahmoud Ahmed, Aziz, Mohamed Abd Elalem
Publicado 2021